These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Expression and significance of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx]. Zhao EM; Han DM; Yu ZK; Fan EZ; Li Y Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):39-42. PubMed ID: 12778766 [TBL] [Abstract][Full Text] [Related]
4. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
5. Plasminogen activators and their inhibitor gene expression in cutaneous NF1-related neurofibromas. Sirén V; Peltonen J; Vaheri A Arch Dermatol Res; 2006 Mar; 297(9):421-4. PubMed ID: 16408192 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts. Allan EH; Martin TJ J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231 [TBL] [Abstract][Full Text] [Related]
7. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines. Buø L; Bjørnland K; Karlsrud TS; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen HT; Aasen AO Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665 [TBL] [Abstract][Full Text] [Related]
8. Elimination of hydrocortisone from the medium enables tissue plasminogen activator gene expression by normal and immortalized nonmalignant human epithelial cells. Myöhänen H; Virtanen I; Vaheri A Biol Chem; 2001 Nov; 382(11):1563-73. PubMed ID: 11767946 [TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator mediated degradation of subendothelial extracellular matrix by human squamous carcinoma cell lines. Niedbala MJ; Sartorelli AC Cancer Commun; 1990; 2(5):189-99. PubMed ID: 2142433 [TBL] [Abstract][Full Text] [Related]
10. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas. Foca C; Moses EK; Quinn MA; Rice GE Gynecol Oncol; 2000 Nov; 79(2):244-50. PubMed ID: 11063652 [TBL] [Abstract][Full Text] [Related]
11. Spitz naevi may express components of the plasminogen activation system. Ferrier CM; Van Geloof WL; Straatman H; Van De Molengraft FJ; Van Muijen GN; Ruiter DJ J Pathol; 2002 Sep; 198(1):92-9. PubMed ID: 12210068 [TBL] [Abstract][Full Text] [Related]
12. Expression of plasminogen activators in basal cell carcinoma. Spiers EM; Lazarus GS; Lyons-Giordano B J Pathol; 1996 Mar; 178(3):290-6. PubMed ID: 8778334 [TBL] [Abstract][Full Text] [Related]
13. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines. Quax PH; van Leeuwen RT; Verspaget HW; Verheijen JH Cancer Res; 1990 Mar; 50(5):1488-94. PubMed ID: 2105839 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system. Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451 [TBL] [Abstract][Full Text] [Related]
15. Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer. Castelló R; Landete JM; España F; Vázquez C; Fuster C; Almenar SM; Ramón LA; Radtke KP; Estellés A Thromb Res; 2007; 120(5):753-62. PubMed ID: 17258797 [TBL] [Abstract][Full Text] [Related]
16. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development. Teesalu T; Blasi F; Talarico D Dev Dyn; 1998 Sep; 213(1):27-38. PubMed ID: 9733098 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of epidermal growth factor-induced invasion by dexamethasone and AP-1 decoy in human squamous cell carcinoma cell lines. Shiratsuchi T; Ishibashi H; Shirasuna K J Cell Physiol; 2002 Dec; 193(3):340-8. PubMed ID: 12384986 [TBL] [Abstract][Full Text] [Related]
18. Plasminogen activators and inhibitors are transcribed during early macaque implantation. Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823 [TBL] [Abstract][Full Text] [Related]
19. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2. Gross TJ; Sitrin RG J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845 [TBL] [Abstract][Full Text] [Related]
20. Modulation of tPA, PAI-1 and PAI-2 antigen and mRNA levels by EGF in the A431 cell line. George F; Pourreau-Schneider N; Arnoux D; Boutière B; Dussault N; Roux-Dosseto M; Alessi MC; Martin PM; Sampol J Blood Coagul Fibrinolysis; 1990 Dec; 1(6):689-93. PubMed ID: 2133249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]